Intimation of Investor Presentation - Q4 & FY 26.
MUKKA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Mukka Proteins released its Q4 & FY26 investor presentation reporting FY26 revenue of ₹1,449.5 Cr, up 44% from ₹1,006.4 Cr in FY25. Full-year EBITDA stood at ₹145.3 Cr with 10.0% margin, while PAT reached ₹57.1 Cr with 3.9% margin. Q4 FY26 showed strong sequential improvement with revenue of ₹653.5 Cr, EBITDA of ₹53.2 Cr, and PAT of ₹49.2 Cr. The company operates four verticals: Fish Protein (25-30% market share), Alternate Proteins (insect protein via Black Soldier Fly), Waste Management (₹474.89 Cr Bengaluru contract), and Frozen Seafood. Management set a FY30 revenue target of ₹3,000+ Cr, implying more than 2x growth in approximately four years. Strategic initiatives include MarinTrust certification, Sri Lanka expansion, and an upcoming 21,249 sq mt Oman facility.
The strong revenue growth and multi-year guidance target position Mukka Proteins as a high-growth play in sustainable protein and waste management, though the slight margin compression warrants monitoring. The ₹474.89 Cr Bengaluru waste management contract provides near-term revenue visibility.